TIMP2 and triple-negative breast carcinoma: TIMP2 was significantly up-regulated in ER-negative group (P = .0014), basal-like group and basal-like (P < .0001), and triple negative breast cancer group (P = .0060) (Fig. 3B, H, and J, Table 2).